|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 10702135.4 (espacenet) (Federated) (European Patent Register), 20100203 | Patent/reg. no. and date | DK/EP 2393413, 20151014 | Publication date | 20111214 | Priority no. and date | EP 09001564, 20090204 | EP pub. no. and date |
EP 2393413 20111214 | Effective date | | Applicant/owner | Sanofi-Aventis Deutschland GmbH, Brüningstraße 50 65929 Frankfurt am Main, DE | Applicant ref. no. | Sanofi DE DE2009/013EPEPT | Inventor | TUBB, Andrew, c/o sanofi-aventis Département Brevets 174 Avenue de France
F-75013 Paris, FR | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61B 5/00 (2006.01) , G06F 19/00 (2011.01) | Title | MEDICINSK ANORDNING OG FREMGANGSMÅDE TIL GLYKÆMISK KONTROL | Int. application no. | EP2010051266 | Int. publication no. | WO2010089305 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |